is bpc 157 intramuscular or subcutaneous Injectable Healing Peptide BPC-157 Site Injection Instructional Video w/ John Tsikouris Subcutaneous Peptide Injection

doi: 10.1046/j.1523-1747.1998.00402.x 52 KirschnerRDSangerKMullerGAEngelandK

BPC-157 naturally migrates to areas of tissue damage even when injected at distant sites

However, it is not recommended for use in newborns or premature infants, as neonates lack the metabolic capacity to process benzyl alcohol safely a contraindication explicitly noted in FDA guidance on benzyl alcohol toxicity in neonates

Different reconstitution volumes produce different concentrations from the same vial: 50mg vial + 2ml water = 25mg/ml (very concentrated) 50mg vial + 2.5ml water = 20mg/ml (concentrated) 50mg vial + 5ml water = 10mg/ml (standard) 50mg vial + 10ml water = 5mg/ml (dilute) Higher concentrations require smaller injection volumes but may exceed solubility limits for some peptides